case series:Drug intervention

2 trials

Sponsors

The First Affiliated Hospital of Zhejiang University, The Second Affiliated Hospital of Chongqing Medical University

Conditions

Colorectal cancerureteral stent removal

Phase 2

A prospective, non-interventional, multicenter clinical study to explore the efficacy and safety of camrelizumab in combination with regorafenib in patients with advanced colorectal cancer

RecruitingChiCTR1900027398

The First Affiliated Hospital of Zhejiang UniversityColorectal cancer

Start: 2019-11-11Updated: 2019-11-18

Phase 4

95% effective dosage of infusion esketamine in ureteral stent removal

RecruitingChiCTR2200062077

The Second Affiliated Hospital of Chongqing Medical Universityureteral stent removal

Start: 2022-07-23Updated: 2023-04-03